The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer. [electronic resource]
Producer: 20150213Description: 713-7 p. digitalISSN:- 1525-1438
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- genetics
- Endometrial Neoplasms -- drug therapy
- Everolimus
- Female
- Humans
- Immunoenzyme Techniques
- Immunosuppressive Agents -- therapeutic use
- Mutation -- genetics
- Neoplasm Grading
- PTEN Phosphohydrolase -- metabolism
- Polymerase Chain Reaction
- Prognosis
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins p21(ras)
- Ribosomal Protein S6 Kinases, 70-kDa -- metabolism
- Sirolimus -- analogs & derivatives
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- ras Proteins -- genetics
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.